adenosine has been researched along with Granulocytic Leukemia, Chronic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Attrotto, C; Capuano, E; Ceci Ginistrelli, L; de Pretis, S; Fatica, A; Fazi, F; Franceschini, L; Iaiza, A; Ianniello, Z; Marchioni, M; Masciarelli, S; Ottone, T; Pelizzola, M; Rizzo, M; Sorci, M; Tito, C; Voso, MT | 1 |
| Ayres, ML; Chen, LS; Gandhi, V; Keating, MJ; Nowak, BJ; Pillai, RN; Shpall, EJ; Thomas, MW | 1 |
| Frankfurt, O; Platanias, LC | 1 |
3 other study(ies) available for adenosine and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
New insight into the catalytic -dependent and -independent roles of METTL3 in sustaining aberrant translation in chronic myeloid leukemia.
Topics: Adenosine; Catalysis; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Gene Knockdown Techniques; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methyltransferases; Models, Biological; Protein Biosynthesis; Proto-Oncogene Proteins c-myc; RNA-Binding Proteins; RNA, Messenger; Up-Regulation | 2021 |
Multifaceted actions of 8-amino-adenosine kill BCR-ABL positive cells.
Topics: Adenosine; Adenosine Triphosphate; Antineoplastic Agents; Apoptosis; Benzamides; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Gene Expression Regulation, Leukemic; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Transcription, Genetic | 2012 |
Non-tyrosine kinase inhibitor-targeting of BCR-ABL expressing cells.
Topics: Adenosine; Fusion Proteins, bcr-abl; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2012 |